XClose

UCL Cancer Institute

Home
Menu

Online: CRUK RadNet City of London Seminar Series

16 March 2022, 4:00 pm–5:00 pm

RadNet Seminar Samuel Bakhoum

Dr Samuel Bakhoum, group leader in the Human Oncology and Pathogenesis Program and physician in Radiation Oncology, Memorial Sloan Kettering Cancer Center, presents: 'Genomic instability-induced inflammation: a friend or a foe?'

Event Information

Open to

All

Availability

Yes

Organiser

CRUK-UCL Centre

Location

Online
Torrington Place
London
WC1E 7JE

Hosted by Dr Sarah McClelland, group leader from Barts Cancer Institute, we warmly welcome Dr. Samuel Bakhoum, group leader in the Human Oncology and Pathogenesis Program and physician in Radiation Oncology at Memorial Sloan Kettering Cancer Center, to join us and deliver a seminar talk on 'Genomic instability-induced inflammation: a friend or a foe?'

Speaker:

Samuel F. Bakhoum is a physician-scientist and group leader in the Human Oncology and Pathogenesis Program and an attending physician in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. His laboratory focuses on understanding the causes and consequences of chromosomal instability in cancer.

Dr. Bakhoum’s group established a critical link between chromosomal instability and cancer metastasis through the generation of chronic inflammation, leading to the identification of novel therapeutic approaches and drug targets that are selective to tumors with chromosomal instability.

Dr. Bakhoum is also a scientific cofounder and a member of the board of directors of Volastra Therapeutics, a biotech startup company aiming to target chromosomal instability in advanced and metastatic cancers.